Stay up-to-date on our progress

The second annual ALADDIN meeting convenes in Linköping in September 2025 

The project consortium will come together in Linköping, in southern Sweden, on the 3rd and 4th of September. 

Read more

blog series

ALADDIN partners in the spotlight:
Linköping University

Read more

blog series

ALADDIN partners in the spotlight: CNB

Read more

First ALADDIN annual meeting: Reflections on the first year and a look ahead 

The meeting allowed the partners to share their progress from the first months of the project and discuss potential future directions. 

Read more

LATEST NEWS!

The ALADDIN consortium gathers in Madrid on 16-17 October 2024

Read more

The ALADDIN digital channels have been launched!

Discover our project website and follow us on X and LinkedIn.

Together with the kick-off of ALADDIN at the beginning of 2024, we have officially launched the digital communication channels of our project. You can find the key information about ALADDIN here, on our website – we particularly encourage you to follow the News page for insights regarding the progress of our project.

ALADDIN (Accelerated Discovery Nanobody Platform) aims at developing and bringing to the market a platform that improves the discovery of therapeutic nanobodies and their preclinical validation for human cancer. The project is funded in the EIC Pathfinder Open programme of the European Innovation Council and SMEs Executive Agency (EISMEA).

Learn more

Contact the ALADDIN team

Read more

This project has received funding from the EIC Pathfinder programme 2023 of the European Innovation Council (EIC) under Grant Agreement#101130574. This result only reflects the author’s view, and the EU is not responsible for any use that may be made of the information it contains.

©2025 copyright ALADDIN Consortium members. Confidential. All rights reserved.

info@aladdin-project.eu

This project has received funding from the EIC Pathfinder programme 2023 of the European Innovation Council (EIC) under Grant Agreement#101130574. This result only reflects the author’s view, and the EU is not responsible for any use that may be made of the information it contains.

©2025 copyright ALADDIN Consortium members. Confidential. All rights reserved.

info@aladdin-project.eu